Tables, Figures, and Maps
Tables
11.6.1. Ten most common invasive neoplasms, and estimated new cases as percentage of all new cases in
the United States, 1990 page 104
11.6.2. Deaths due to cancer as percentage of all deaths according to sex and age group,
United States, 1986 104
11.6.3.
Most common cancers as causes of death from cancer, according to sex and age group, United States,1986 104
∏.6.4. Five-year survival rates by race in two time periods from principal malignant neoplasms in the United States 105
IIL8.1. U.S. tobacco production and consumption, 1900-88 180
111.8.2. Per capita adult consumption of
cigarettes, by country, 1985 181
111.8.3. Percentage of U.S. adults who
smoked regularly, 1945-85 182
111.8.4. Deaths and mortality rates among
smoking U.S. veterans, 1980 183
ΠI.8.5. Estimated number of deaths caused by cigarette smoking in the United States, 1980 184
ΓV.2.1. Birthrates and maternal deaths ∣
in England and Wales, 18511980 214
ΓV.3.1. Infant mortality rates for income areas in metropolitan Ohio, 1979-81 227
ΓV.3.2. Infant mortality rates by broad cause-of-death group for income areas in metropolitan Ohio, 1979-81 228
IV. 4.1. Abridged life table for Sweden,
1751-90 232
V. 8.1. Healed fracture frequencies for
North American prehistoric remains 308
V. 9.1. Diseases suggested to have been introduced to the Americas 322
V. 9.2. Viral, bacterial, and protozoal
agents introduced to the Americas 324
VI. 3.1. Leading causes of death, selected
cities and counties of Shanghai, 1957 and 1984 363
VI. 3.2. Leading provincial causes of death in China, 1985 364
VI. 3.3. Communicable diseases in China,
1985 365
VII. 8.1. Incidents of serious contamination
in U.S. work sites and residential areas 531
VIII. 10.1. 512 recognized arboviruses listed
by family and subcategories, with totals 588
VIII.
10.2. Size, morphology, structure, and composition of selected virus families or genera that contain arboviruses 590VIIL 10.3. Twenty-nine selected arboviruses important in causing human and/or animal diseases, with data on vectors, hosts, and geographic distributions 591
VIIL 11.1. History and natural occurrence of arenaviruses 596
VIII.19.1. Types of Clostridium botulinum, susceptible species, and sites of outbreaks 623
VΠI.19.2. Reportsofbotulismfrom
various countries in recent
years 624
VΠI.28.1. Etiology and incidence of
cirrhosis 650
VΠI.30.1. Classification of crouplike
illnesses 654
VΠI.34.1. Causes and suspected causes
of, and risk factors for,
diabetes 668
VΠI.34.2. Prevalence of diagnosed diabetes
in representative populations,
1960-85 671
VΠI.34.3. Diabetes mortality trends by
country and geographic area,
1970-2 and 1976-83 (rates per
100,000 population) 672
VIII.35.1. Commonly identified etiologic
agents in diarrheal disease 678
VΠI.35.2. Etiologic agents of diarrhea,
characteristically identified in
special settings 678
VIII.36.1. Diphtheria mortality rate per
100,000 population 683
VΠI.42.1. Ebola serosurveys 700
VIII.46.1. Time interval from encephalitis
to parkinsonism to death in six
patients 711
VΠI.58.1. Causes of gangrene 742
VIII.63.1. Occurrence of nephrolithiasis
with gout 765
VIII.63.2. Prevalence of hyperuricemia 768
VIII.63.3. Prevalence of gout in relation
to serum uric acid content in
men 769
VIII.63.4. Serum uric acid in two
American Indian tribes 769
VIII.63.5. Serum uric acid in South
African black and white
populations 771
VΠI.69.1. Prevalenceofhypertensionin
20- to 59-year-olds, by region, in
ascending order by prevalence:
52 populations, INTERSALT
Study, 1988 790
VΠI.69.2. Relationship between blood
pressure and mortality:
Northwestern Mutual Life
Insurance Company, 1907—14 793
VΠI.69.3.
“Normal” and “unacceptable”systolic blood pressures by
age: Northwestern Mutual
Life Insurance Company,
1914 793
VΠI.75.1. Lactose absorption and
malabsorption correlated with
degree of Indian blood
Xlll
(children ≥ 4 years, and adults) 815
VΠI.75.2. Distribution of the adult lactase phenotypes in human populations 815
VΠI.76.1. Lassa fever outbreaks: West
Africa, 1969-88 818
VIIL81.1 Serologic classification of
Ieptospires 841
VIII.81.2. Symptoms occurring in
leptospiroses 842
VΠI.85.1. Malaria in 1984 857
VIII.86.1. Serologic studies OfMarburg
virus in humans and other primates 863
VIIL 110.1. Comparison of paralysis of
lower limbs in temperate and developing countries 946
VIII.117.1. Age distribution of admissions for acute rheumatic fever 972
VIII. 117.2. Cases of rheumatic fever per
1, 000 admissions, various hospitals 973
VIII.117.3. Signs of acute rheumatic fever worldwide 975
VIIL 134.1. Etiology, epidemiology, and clinical manifestations of the human treponematoses 1026
VIII.154.1. Major features differentiating bladder and renal stone disease 1089
VIIL 154.2. Paleopathological specimens of renal and bladder stones 1091
Figures
11.5.1. Rate of coronary heart disease per 100,000 people in the
United States 96
11.5.2. Annual change in mortality
from ischemic cardiac disease, 1968-77 96
III. 1.1. Mixed model Ofliability for
complex human disease 114
ΠI.1.2. A representation of metabolic
pathways involving the amino acid tyrosine 119
ΠI.1.3. The original two-dimensional chromatographic spreads of normal and sickle-cell hemoglobins 121
III. 1.4. G-banded chromosome spread of a man with Down syndrome and ideogram of human chromosome 21 123
III.5.1. Relation of social cooperation to ecological stress in a social action system 159
ΠI.8.1. Annual consumption of cigarettes by U.S. adults, 1900-88 179
ΠI.8.2.
Cigarette consumption and tobaccosis mortality in the United States, 1900-87 184III. 8.3. The price of pleasure: deaths
from addictive substances and AIDS in the United States, 1980s 185
ΓV.2.1. Birthrates and maternal mortality rates for England and
Wales, 1851-1980 215
ΓV.2.2. Maternal mortality rates for England and Wales, 1851-1980 215
ΓV.2.3. Maternal mortality rates in different countries, 1880-1950 216
IV. 2.4. Maternal mortality rates in
Scotland, England, Wales, and
Sweden, 1870-1950 217
IV. 2.5. Maternal mortality rates in England, Wales, and the United
States, 1910—50 219
IV. 4.1. Survival curves 231
IV. 4.2. Mortality risk for medieval
Hungary, England (1871-80), and the United States (1979-81) 234
ΓV.4.3. Morbidity rates for nineteenthcentury Britain 235
ΓV.4.4. Mortality schedules for Sweden, 1816-40 and 1979-83 236
V. 1.1. Probable unhealed ax wound in
an adult male skull, 1100-655 B.C. 249
V. 1.2. Partial antemortem destruction of the fourth lumbar vertebral body from the skeleton of a young adult, 3100 B.C. 251
V. 1.3. Chronic inflammation of the left tibia and fibula in an adult woman, Early Bronze Age 252
V. 1.4. Dental caries in an adult male, Early Bronze Age 255
V.1.5. Benign tumor in the area of fusion between the pubic and iliac bones of an adult woman, c. 1990 B.C. 257
V. 1.6. Malignant tumor of the proximal left humerus of a Celtic warrior, 800-600 B.C. 257
V.8.1. Model time line for prehistoric
eastern North America 306
V.8.2. Model time line for prehistoric
Peru and Chile 307
V. 8.3. Different methods of trepanation 307
VI. 1.1. Oracle-bone and bronze terms
specifying disease entities 346
VI. 3.1. Mortality rates for the urban
population of Shanghai, 194983 363
VIIL2.1. Glossina palpalis 552
VIII.2.2. Glossina morsitans 552
VΠI.20.1. Graphs illustrating the dramatic
reduction in the incidence of brucellosis in the British garrison in Malta from 1905 to 1907, following the ban on the use of goat’s milk 627
VIII.22.1.
Bartonella bacilliformis within red blood cells stained by Giemsa and Romanovsky stains 632VIII.22.2. Verrucose eruptions: miliary form, diffuse and generalized; nodular form, two intradermic nodules; and mular form 633
VIII.22.3. Intracellular reproduction cycle of the Bartonella bacilliformis in the cytoplasm of a histiocytic bone marrow cell and the endothelial cells of a lymph node 633
VIII.22.4. Erythrophagocytosis of parasitized erythrocytes in peripheral blood and spleen 634
VIII.25.1. Megaesophagus from a case of possible Chagas’ disease from the Tarapaca Valley in northern Chile (c. third century A.D.) 638
VIII.46.1. Encephalitis lethargica, influenza-pneumonia, other pneumonia/bronchitis deaths in Seattle-King County,
Washington, 1918-26 709
VIII.60.1. Urine-secreting structure
(nephron) 746
VIII.60.2. Normal glomerulus 746
VIII.60.3. Acute glomerulonephritis 747
VIII.62.1. Gonorrhea incidence in selected
countries, 1940-83 758
VIII.62.2. Gonorrhea rates in men and
women, aged 20-4, United States,
1956-85 759
VIII.62.3. Gonorrhea: age-specific rates for
men and women, United States,
1985 759
VΠI.62.4. Distribution of gonorrhea in
Denver, Colorado, 1974-6 761
VIII.62.5. Occurrence of gonorrhea in
Buffalo, New York, 1975-80;
distribution of core and adjacent
tracts 762
VIII.62.6. Penicillinase-producing Neisseria
gonorrhea (PPNG) as a
percentage of total gonorrhea, by
zip code analysis in Miami,
Florida, March 1985 to
February 1986 762
VIIL64.1. Percentage distribution of
antibodies to HSV-1, HSV-2, and intermediate form (types 1 and 2) in 239 patients of various age groups 774
VΠI.64.2. Number of consultations, all
five office visits, and first of five visits for genital herpes, United States, 1966-83 774
VΠL64.3. Schematic graph of the
clinical course of primary
genital herpes 776
VIII.77.1. World lead production during
past 5,500 years 822
VIII.79.1.
The uta form of leishmaniasis 833VIII.81.1. Leptospires on dark field 840
VIII.81.2. Phases and relevant
diagnostic procedures of leptospiroses 841
VIIL 100.1 Severe Paget’s disease of the
bone in a 66-year-old male 912
VIII.102.1. Scheme illustrating the
mechanism of MPTP toxicity at nigral dopamine neurons in primates 916
VIIL 110.1. Cases of paralytic
poliomyelitis in Malta, 1920
64 943
VIII.110.2. Case-fatality rates for
poliomyelitis based on records from England and Wales, 1947-50 (average of male and female rates; 28 notified cases); Denmark, 1947-50 (28 paralytic cases); France, 1952 (average of male and female rates; 28 notified cases); Sweden 1935-44 (28 confirmed paralytic cases); Eskimos, Chesterfield Inlet (14 cases); Cutter vacinees (27 cases); West Virginia, (18 cases); Malta, 1942-3 (service cases, 20-30 years of age, number of cases not specified); Sweden, 1911-13 (5 cases) 944
VIII.110.3. Numbers Ofpublications
about polio by year, 1890 to
1986; the Current Bibliography of Poliomyelitis, Index Medicus, and the Bibliography of Infantile
Paralysis 947
VIII. 110.4. Age of onset of cases of
poliomyelitis in developing
countries, compared with Miami, Florida, United States, 1948-9 949
VΠI.122.1. Woodcut of St. Anthony by Johannes Wechtlin 990
VΠI.134.1. Two hypotheses as to the possible evolution of the organisms responsible for human treponematoses 1027
VIIL 134.2. Infectious diseases considered as a dynamic triangular interaction among host, parasite, and environment 1029
Maps
IV.2.1. Differences in maternal mortality rates in England and Wales, 1924-33 218
ΓV.2.2. Differences in maternal mortality rates in the United
States, 1938-40 219
VII. 3.1. General endemicity of cholera, malaria, and “kangri burn” cancer 466
VII. 3.2. Malaria: annual parasite index (API), per 1,000 population, for selected years 469
VII. 3.3. Leprosy: prevalence rate
percentage, 1974-5 471
VII. 3.4. General distribution of
filariasis and goiter 472
VII.8.1. Diffusion of smallpox among
native Americans, 1928 524
VII.8.2. Diffusion of smallpox among
native Americans, 1983 525
VII.8.3. Malarial disease deaths per
1,000 population, 1870 527
VII.8.4. “Consumption” deaths per
1,000 population, 1870 528
VII. 8.5. Leprosy area of New
Brunswick, predominantly in the nineteenth century 529
VIII. 2.1. Distribution of African
sleeping sickness Ipalpalis group) 553
VIIL2.2. Distribution of African sleeping sickness Ijnorsitans group) 553
VIII. 38.1. Areas in which dracunculiasis is reported or probably exists 687
VΠI.80.1. Estimated endemicity of leprosy in the world, 1983 835
Vm.120.1. Epidemiological map of Rocky Mountain spotted fever in Bitterroot Valley, Montana, 1902 983
VIII. 124.1. Distribution of Schistosoma
haematobium in Africa and the Middle East 993
VIIL 124.2. Distribution OiSchistosoma mansoni in Africa and the Middle East 993
VIII. 124.3. Distribution OiSchistosoma mansoni in the Western Hemisphere 994
VHL 124.4. Distribution of Schistosoma japonicum and Schistosoma mekongi 994
VIII.151.1. Outline map of the world (c ∙ World War II), showing the approximate geographic distribution of epidemic (exanthematic) louse-bome typhus, murine (endemic) flea-borne typhus, and Brill’s disease 1082
VHI.153.1. Known geographic distribution of mite (scrub) typhus in Asia, July 1948 1086